This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Astrazeneca Ab, Kudos Pharmaceuticals Limited. Active years: 2013-2023.
Location History:
- Ludwigshafen, DE (2013)
- Macclesfield, GB (2023)
Company Filing History:
Years Active: 2013-2023
Title: Michael Karl Bechtold: Innovator in Pharmaceutical Formulations
Introduction
Michael Karl Bechtold is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Bechtold's work focuses on enhancing the bioavailability of pharmaceutical compounds.
Latest Patents
Bechtold's latest patents include an immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one. This invention relates to a pharmaceutical formulation that comprises the drug in a solid dispersion with a matrix polymer exhibiting low hygroscopicity and high softening temperature, such as copovidone. The formulation aims to provide a daily pharmaceutical dose of the drug while increasing its bioavailability.
Career Highlights
Throughout his career, Michael Karl Bechtold has worked with prominent companies in the pharmaceutical industry, including Kudos Pharmaceuticals Limited and AstraZeneca AB. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Bechtold has collaborated with various professionals in the field, including Julie Kay Cahill and Bernd Harald Liepold. These collaborations have likely enriched his research and development efforts.
Conclusion
Michael Karl Bechtold is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact drug delivery and efficacy. His innovative approaches continue to advance the field of pharmaceuticals.